Soterix Medical Inc. (SMI) was formed to develop and deploy innovative medical treatments focused on neuropsychiatric and neurological disorders and rehabilitation. Founded in 2008, SMI is the world leader in clinical trials for non-invasive neuromodulation working with over 250 medical centers in the US and worldwide. SMI has licensed and developed a comprehensive intellectual property portfolio that includes High-Definition transcranial Direct Current Stimulation (HD-tDCS), Limited Total Energy tDCS (LTE-tDCS), and Neurotargeting. From the most targeted non-invasive clinical systems to the most portable units, Soterix Medical provides clinicians and patients with unique and adaptable solutions. Ongoing Phase I, II, IIb, and III trials use investigational devices that are regulated/limited by US or Federal law. SMI is proudly based in New York City with international distributors in all major markets.

Engineering Serving Humanity

At Soterix Medical, Engineering Serving Humanity means that we are committed to bring the most advanced medical technology into the hands of people who need it. The commitment underpins everything we do.

tDCS⁺ PET

Integration of Positron Emission Tomography (PET) and tDCS

In many instances, tDCS can be applied directly in a PET/CT without concern for artifacts that can occur during EEG or fMRI monitoring. Soterix Medical biomedical engineers work with leading clinical investigators to ensure scanner specific compatibility and trial rigor. For example, investigators at University of Michigan initiated their landmark study to investigate the actions of tDCS on release endogenous opioids, Soterix Medical provided support on instrumentation designing including ensuring full electrode saturation during extended scanning sessions, custom EASYstrap head-gear for supine resting subjects, and co-registration of imaging and current flow data. Soterix Medical is ready to assist in the rational design of PET and tDCS studies ensuring every experimental confound from subject tolerability and stimulation stability is controlled. Clinical researchers and subjects enrolled in PET studies deserve the best equipment and rational experimental design. As needed, Soterix Medical is on site.